Why the study?
Do chronic heart failure and heart transplant patients have altered electromyographic cost and cost of transport during walking compared to healthy controls?
Do chronic heart failure and heart transplant patients have altered electromyographic cost and cost of transport during walking compared to healthy controls?
Chronic heart failure and heart transplant patients exhibit higher electromyographic and metabolic costs during walking, suggesting that improving muscle performance could enhance walking economy.
Gait inefficiency may contribute to intolerance in HF and transplant patients; leaves open whether targeted training improves walking economy.
Background Patients with chronic heart failure frequently report intolerance to exercise and present with changes in walk pattern, but information about heart transplant patients is lacking. Alterations of the gait pattern are related to interaction changes between the metabolism, neurological system and the mechanical demands of the locomotor task. The aim of this study was to investigate the electromyographic cost, coactivation and cost of transport of walking of chronic heart failure and heart transplant patients. Design This research was of an exploratory, cross-sectional design. Methods Twelve chronic heart failure patients, twelve healthy controls and five heart transplant patients participated in the study. Electromyographic data and oxygen uptake were collected simultaneously at five walking speeds. Results In the experimental groups, the electromyographic cost, percentage of coactivation in the leg and cost of transport were higher than in controls. The electromyographic cost was in line with the cost of transport. The minimum electromyographic cost matched with the self-selected walking speed in controls, while in chronic heart failure and heart transplant patients, it was reached at speeds higher than the self-selected walking speed. Conclusion The largest postural isometric activation and antagonist activation resulted in the highest metabolic demand. These findings are of great clinical relevance because they support the concept that interventions in order to improve the muscle performance in these patients can increase the self-selected walking speed and therefore the metabolic economy of walking.
No takes yet. Share an insight, caveat, or question.
Bona et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: